Health Products

CellChem Pharmaceuticals Ondansetron Product Recall (2019-10-16)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III

Summary

Product

A.  CCP-Ondansetron 8 mg Tablet;    

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDIN, NPN, DIN-HIMDosage formStrength
409423B.  CCP-Ondansetron 4 mg Tablet
Recalling Firm
Cellchem Pharmaceuticals Inc
Unit 1, 30 Concourse Gate,
Ottawa
K2E 7V7
Ontario
CANADA
Marketing Authorization Holder
Cellchem Pharmaceuticals Inc
Unit 1, 30 Concourse Gate,
Ottawa
K2E 7V7
Ontario
CANADA
DIN 0245880TabletOndansetron 4 mg
409424A.  CCP-Ondansetron 8 mg Tablet
Recalling Firm
Cellchem Pharmaceuticals Inc
Unit 1, 30 Concourse Gate,
Ottawa
K2E 7V7
Ontario
CANADA
Marketing Authorization Holder
Cellchem Pharmaceuticals Inc
Unit 1, 30 Concourse Gate,
Ottawa
K2E 7V7
Ontario
CANADA
DIN 02458802TabletOndansetron 8 mg

Introduction

A.  CCP-Ondansetron 8 mg Tablet;   

B.  CCP-Ondansetron 4 mg Tablet

Reason

Affected lot is labelled with the incorrect indication found on the inner label.

Depth of distribution

Retailers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime